AstraZeneca's SWOT analysis: pharma giant's stock poised for growth amid...

Published on 30 Jan 2025 on Investing.com

AstraZeneca PLC (LON:AZN), a leading global biopharmaceutical company with a market capitalization...

Read the rest of the article

Start tracking your investments with Statfolio

(Bloomberg) -- A revival in AstraZeneca Plc shares faces a key test this week, with more likely t...

Bloomberg · via Yahoo Finance 3 Feb 2025

(Bloomberg) -- Stocks are ending a wild week on a positive note after solid forecasts from tech...

Bloomberg · via Yahoo Finance 31 Jan 2025

AstraZeneca PLC (LON:AZN), a leading global biopharmaceutical company with a market capitalizatio...

Investing.com 30 Jan 2025

(Bloomberg) -- Sanofi said it will repurchase €5 billion ($5.2 billion) of stock and grow profits...

Bloomberg · via Yahoo Finance 30 Jan 2025

Astrazeneca (AZN) AstraZeneca plc, headquartered in London, UK, is one of the largest biopharmace...

Zacks · via Yahoo Finance 29 Jan 2025

This AZN drug is currently approved for two indications, namely eosinophilic asthma and EGPA....

Zacks · via Yahoo Finance 29 Jan 2025

In the first nine months of 2024, Enhertu generated $1.05 billion in alliance revenues for...

Zacks · via Yahoo Finance 28 Jan 2025

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article...

Insider Monkey · via Yahoo Finance 22 Jan 2025

The FDA's nod is based on late-stage data, which show AZN's Datroway cuts the risk of disease...

Zacks · via Yahoo Finance 20 Jan 2025

This investing style is all about taking advantage of upward or downward trends in a stock's pric...

Zacks · via Yahoo Finance 20 Jan 2025